Subscribe To
Twist bioscience, eleven therapeutics create synthetic viral rna molecules to develop antiviral vaccines, therapeutics
Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication,...
February 7, 2022, 10:09 am
Twist bioscience, eleven therapeutics create synthetic viral rna molecules to develop antiviral vaccines, therapeutics
Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication,...
February 7, 2022, 10:09 am
Covid-19: pfizer vaccine for kids under 5 ‘really good news,' doctor says
Dr. Payal Patel, infectious diseases physician at the University of Michigan, joins Yahoo Finance's Emi...
February 1, 2022, 5:12 pm
Covid-19: pfizer vaccine for kids under 5 ‘really good news,' doctor says
Dr. Payal Patel, infectious diseases physician at the University of Michigan, joins Yahoo Finance's Emi...
February 1, 2022, 5:12 pm
Covid-19: pfizer vaccine for kids under 5 ‘really good news,' doctor says
Dr. Payal Patel, infectious diseases physician at the University of Michigan, joins Yahoo Finance's Emi...
February 1, 2022, 5:12 pm
Aethlon medical to release third quarter financial results and host conference call on february 14, 2022
SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threat...
January 31, 2022, 8:01 am
Aethlon medical to release third quarter financial results and host conference call on february 14, 2022
SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threat...
January 31, 2022, 8:01 am
Aethlon medical to release third quarter financial results and host conference call on february 14, 2022
SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threat...
January 31, 2022, 8:01 am
Pharmadrug initiates manufacturing of pd-001 for clinical programs in rare cancers and covid-19
PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clini...
January 26, 2022, 9:34 am
Pharmadrug initiates manufacturing of pd-001 for clinical programs in rare cancers and covid-19
PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clini...
January 26, 2022, 9:34 am
Pharmadrug initiates manufacturing of pd-001 for clinical programs in rare cancers and covid-19
PharmaDrug Inc announced that it has initiated the manufacturing of PD-001, a patented enteric-coated oral formulation of cepharanthine, for non-clini...
January 26, 2022, 9:34 am
Biondvax to present at edison group's open house conference
JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturin...
January 26, 2022, 7:39 am
Biondvax to present at edison group's open house conference
JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturin...
January 26, 2022, 7:39 am
Biondvax to present at edison group's open house conference
JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturin...
January 26, 2022, 7:39 am
Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation
GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a bo...
December 27, 2021, 1:46 pm
Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation
GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a bo...
December 27, 2021, 1:46 pm
Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation
GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a bo...
December 27, 2021, 1:46 pm
Studies claim pfizer vaccine is less effective after a few months, plus cdc booster guidance
Dr. Payal Patel, infectious Diseases Physician, University of Michigan, joins Yahoo Finance's Jared Bli...
October 8, 2021, 3:43 pm
Studies claim pfizer vaccine is less effective after a few months, plus cdc booster guidance
Dr. Payal Patel, infectious Diseases Physician, University of Michigan, joins Yahoo Finance's Jared Bli...
October 8, 2021, 3:43 pm
Studies claim pfizer vaccine is less effective after a few months, plus cdc booster guidance
Dr. Payal Patel, infectious Diseases Physician, University of Michigan, joins Yahoo Finance's Jared Bli...
October 8, 2021, 3:43 pm